Vizora日本語

Waqoo4937東証グロース化学FY ending Sep 2025, consolidated, J-GAAP

Waqoo FY ending Sep 2025 results

About 51% of Waqoo's sales come from Medical support, with Direct to Consumer business making up much of the rest.

Out of every ¥100 of sales, about ¥8 is left as operating profit.

Revenue changed +0.9% from the prior year, operating profit +169.0%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +0.9% · profit +169.0%, calculated from disclosed figures.

Operating leverage: 187.68× (profit growth ÷ revenue growth)

What changed from last year

FY ending Sep 2024 → FY ending Sep 2025

Revenue
+0.9%¥1.94B → ¥1.96B
Gross profit
+0.6%¥1.55B → ¥1.56B
Operating income
+169.0%¥56.1M → ¥150.9M
Net income attributable to owners
Back to profit-¥17.4M → ¥44.1M
Operating cash flow
+180.2%¥48.7M → ¥136.3M
Free cash flow
Loss-¥31.1M → -¥56.8M

Where the money goes

FY ending Sep 2024 → FY ending Sep 2025

Where ¥100 of sales goes

For every ¥100 Waqoo sells, how much goes where, and how much is kept.

FY ending Sep 2025
Cost of sales
¥20
SG&A
¥72
Operating profit
¥8
Net profit kept
¥2

Annual margin trends

Gross margin79.5%
FY ending Sep 2020: 83.4%83.4%FY ending Sep 2021: 80.7%80.7%FY ending Sep 2022: 70.6%70.6%FY ending Sep 2023: 76.0%76.0%FY ending Sep 2024: 79.7%79.7%FY ending Sep 2025: 79.5%79.5%FY20FY21FY22FY23FY24FY25
Operating margin7.7%
FY ending Sep 2020: 2.4%2.4%FY ending Sep 2021: 3.2%3.2%FY ending Sep 2022: -1.5%-1.5%FY ending Sep 2023: 16.1%16.1%FY ending Sep 2024: 2.9%2.9%FY ending Sep 2025: 7.7%7.7%FY20FY21FY22FY23FY24FY25
Net margin2.2%
FY ending Sep 2020: 2.2%2.2%FY ending Sep 2021: 2.5%2.5%FY ending Sep 2022: -2.1%-2.1%FY ending Sep 2023: 1.6%1.6%FY ending Sep 2024: -0.9%-0.9%FY ending Sep 2025: 2.2%2.2%FY20FY21FY22FY23FY24FY25

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Sep 2025

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (5)

  • EDINET (FSA Japan)

    有価証券報告書－第20期(2024/10/01－2025/09/30)

    ID S100XCAJ2025-12-23Open

  • EDINET (FSA Japan)

    有価証券報告書－第19期(2023/10/01－2024/09/30)

    ID S100UZCZ2024-12-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第18期(2022/10/01－2023/09/30)

    ID S100SIBJ2023-12-21Open

  • EDINET (FSA Japan)

    有価証券報告書－第17期(令和3年10月1日－令和4年9月30日)

    ID S100PV1X2022-12-23Open

  • EDINET (FSA Japan)

    有価証券報告書－第16期(令和2年10月1日－令和3年9月30日)

    ID S100N3RX2021-12-22Open

Extracted from XBRL: 45 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image